Search Results - "MacKenzie, Erin M"
-
1
Exploring life engagement from the perspective of patients with major depressive disorder: a study using patient interviews
Published in Journal of patient-reported outcomes (12-10-2022)“…Background Patient-reported outcomes can measure health aspects that are meaningful to patients, such as ‘life engagement’ in major depressive disorder (MDD)…”
Get full text
Journal Article -
2
Attenuation of the effects of oxidative stress by the MAO-inhibiting antidepressant and carbonyl scavenger phenelzine
Published in Chemico-biological interactions (01-05-2019)“…Phenelzine (β-phenylethylhydrazine) is a monoamine oxidase (MAO)-inhibiting antidepressant with anxiolytic properties. It possesses a number of important…”
Get full text
Journal Article -
3
Effects of Adjunctive Brexpiprazole on Individual Depressive Symptoms and Functioning in Patients With Major Depressive Disorder and Anxious Distress: Post Hoc Analysis of Three Placebo-Controlled Studies
Published in Journal of clinical psychopharmacology (01-03-2024)“…Anxiety symptoms in major depressive disorder (MDD) are frequent, and they decrease response to antidepressant treatment (ADT), and affect patient functioning…”
Get full text
Journal Article -
4
Efficacy of adjunctive brexpiprazole on symptom clusters of major depressive disorder: A post hoc analysis of four clinical studies
Published in Journal of affective disorders (01-11-2022)“…Major depressive disorder (MDD) is a clinically heterogenous condition and its treatment should be individualized according to the presence of particular…”
Get full text
Journal Article -
5
Adjunctive Brexpiprazole for Patient Life Engagement in Major Depressive Disorder: A Canadian, Phase 4, Open-Label, Interventional Study: Brexpiprazole d'appoint pour l'engagement dans la vie des patients souffrant de trouble dépressif majeur: une étude interventionnelle canadienne ouverte de phase 4
Published in Canadian journal of psychiatry (01-07-2024)“…Objectives To characterize the effects of adjunctive brexpiprazole on patient life engagement and depressive symptoms in patients with major depressive…”
Get full text
Journal Article -
6
Effects of adjunctive brexpiprazole on patient life engagement in major depressive disorder: Post hoc analysis of Inventory of Depressive Symptomatology Self-Report data
Published in Journal of psychiatric research (01-06-2023)“…Patient-reported outcomes can capture domains that are meaningful to patients, such as life engagement in major depressive disorder (MDD), which reflects life…”
Get full text
Journal Article -
7
An update on amine oxidase inhibitors: Multifaceted drugs
Published in Progress in neuro-psychopharmacology & biological psychiatry (01-07-2013)“…Although not used as extensively as other antidepressants for the treatment of depression, the monoamine oxidase (MAO) inhibitors continue to hold a niche in…”
Get full text
Journal Article -
8
The histology of sutures in chicken skulls: Types, conservation, and ontogeny
Published in Journal of anatomy (01-03-2022)“…Sutures are fibrous joints that occur between bone elements in vertebrate skulls, where they play a variety of roles including facilitating skull growth and…”
Get full text
Journal Article -
9
Normal development in Xenopus laevis: A complementary staging table for the skull based on cartilage and bone
Published in Developmental dynamics (01-08-2022)“…Background Xenopus laevis is a widely used model organism in the fields of genetics and development, and more recently evolution. At present, the most widely…”
Get full text
Journal Article -
10
Development of the chicken skull: A complement to the external staging table of Hamburger and Hamilton
Published in Anatomical record (Hoboken, N.J. : 2007) (01-12-2021)“…Embryonic staging tables provide a standard of developmental stages that can be used by individual investigators and provide approximate time points for the…”
Get full text
Journal Article -
11
Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine
Published in Cellular and molecular neurobiology (01-01-2022)“…Phenelzine (PLZ) is a monoamine oxidase (MAO)-inhibiting antidepressant with anxiolytic properties. This multifaceted drug has a number of pharmacological and…”
Get full text
Journal Article -
12
Quantification of l-stepholidine in rat brain and plasma by high performance liquid chromatography combined with fluorescence detection
Published in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (01-05-2007)“…A sensitive and reliable assay for the quantification of l-stepholidine (SPD) in rat plasma and brain was developed using high performance liquid…”
Get full text
Journal Article -
13
Monoamine oxidase inhibitors and neuroprotection: a review
Published in American journal of therapeutics (01-11-2012)“…Monoamine oxidase inhibitors have been available for more than 50 years, initially developed as antidepressants but currently used in a variety of psychiatric…”
Get full text
Journal Article -
14
Inhibition of p53 attenuates ischemic stress-induced activation of astrocytes
Published in Neuroreport (30-09-2015)“…In cerebral ischemia, studies of cell death have focused primarily on neurons, but recent work indicates that ischemia also causes damage to astrocytes…”
Get full text
Journal Article -
15
The pharmacology and formulation of paliperidone extended release
Published in Expert review of neurotherapeutics (01-12-2012)“…Paliperidone, or 9-hydroxyrisperidone (Invega(®), Janssen, Antwerp, Belgium) is the major active metabolite of the atypical antipsychotic risperidone…”
Get more information
Journal Article -
16
D-serine and schizophrenia: an update
Published in Expert review of neurotherapeutics (01-07-2012)“…Considering the lengthy history of pharmacological treatment of schizophrenia, the development of novel antipsychotic agents targeting the glutamatergic system…”
Get more information
Journal Article -
17
Comparison of phenelzine and geometric isomers of its active metabolite, β-phenylethylidenehydrazine, on rat brain levels of amino acids, biogenic amine neurotransmitters and methylamine
Published in Journal of Neural Transmission (01-06-2013)“…Phenelzine is a monoamine oxidase (MAO) inhibitor used in treatment of depression and anxiety disorders. It also elevates brain levels of γ-aminobutyric acid…”
Get full text
Journal Article -
18
The relevance of neuroactive steroids in schizophrenia, depression, and anxiety disorders
Published in Cellular and molecular neurobiology (01-07-2007)“…1. Neuroactive steroids are steroid hormones that exert rapid, nongenomic effects at ligand-gated ion channels. There is increasing awareness of the possible…”
Get full text
Journal Article -
19
Phenelzine Causes an Increase in Brain Ornithine that is Prevented by Prior Monoamine Oxidase Inhibition
Published in Neurochemical research (01-03-2008)“…Phenelzine (PLZ), a nonselective irreversible inhibitor of monoamine oxidase (MAO), also inhibits GABA-transaminase (GABA-T), markedly increasing brain GABA…”
Get full text
Journal Article -
20
Cardiac risk and schizophrenia
Published in Journal of psychiatry & neuroscience (01-11-2005)Get full text
Journal Article